Matthew Porteus
Net worth: 11 M $ as of 2024-03-30
Profile
Matthew Porteus is the founder of CRISPR Therapeutics AG, which was founded in 2013.
He is also the founder of Graphite Bio, Inc., which was founded in 2017.
Dr. Porteus's current job is as a Professor at Stanford University and as an Associate Professor at Stanford School of Medicine since 2010.
His former job was as an Assistant Professor at The University of Texas Southwestern Medical Center from 2003 to 2010.
Dr. Porteus's education includes an undergraduate degree from Harvard University and a doctorate from Stanford University.
Dr. Porteus is also the founder of Kamau Therapeutics, Inc...
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
1.97% | 2024-01-31 | 504,075 ( 1.97% ) | 11 M $ | 2024-03-30 |
Matthew Porteus active positions
| Companies | Position | Start |
|---|---|---|
| Stanford School of Medicine | Corporate Officer/Principal | 2010-09-30 |
| Stanford University | Corporate Officer/Principal | - |
Former positions of Matthew Porteus
| Companies | Position | End |
|---|---|---|
| The University of Texas Southwestern Medical Center | Corporate Officer/Principal | 2010-07-31 |
| LENZ THERAPEUTICS, INC. | Founder | - |
| CRISPR THERAPEUTICS AG | Founder | - |
Training of Matthew Porteus
| Harvard University | Undergraduate Degree |
| Stanford University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| CRISPR THERAPEUTICS AG | Health Technology |
| Private companies | 1 |
|---|---|
Graphite Bio, Inc.
 Graphite Bio, Inc. BiotechnologyHealth Technology Graphite Bio, Inc. is a clinical-stage gene editing company. It engages in the business of developing therapies that harness targeted gene integration to treat or cure serious diseases. The company was founded by Matthew Porteus and Maria Grazia Roncarolo on June 1, 2017 and is headquartered in South San Francisco, CA. | Health Technology |
- Stock Market
- Insiders
- Matthew Porteus
